Dr. Mark Sullivan holds undergraduate degrees in Microbiology and Molecular Biology through Washington State University and advanced degrees of Doctor of Medicine and Master of Public Health both through the University of Washington. He is a board certified physician in three specialties of Internal Medicine, Critical Care Medicine, and Occupational/Environmental Medicine with special interest in toxic exposure assessment and treatment. Dr. Sullivan completed his MPH research thesis on the association between transition metal components of < 2.5 micron particulate matter (PM 2.5) and lung function and density as potentially relates to chronic obstructive pulmonary disease (COPD) prevalence. Past research experience includes identifying the structure of the working genome of the Human Foamy Retrovirus at Fred Hutchinson Cancer Research Center, and helping to identify the Alzheimer’s and Werner’s disease gene locus at the University of Washington.
Jared Hooks, PhD
Jared majored in both biochemistry and genetics while attending Texas A&M University for his bachelor’s degree. During this time, he performed research utilizing peptide chemistry, cloning and protein expression, and native chemical ligation to synthesize novel semi-synthetic protein constructs for use as intracellular probes. Jared also holds a PhD in cancer biology from the University of Texas Southwestern Graduate School for Biomedical Sciences. His dissertation work ranged from developing and characterizing a cancer specific, heterodimeric, dual-targeted peptidomimetic compound, to interrogating the TGFβ-dependent regulation of the tumor suppressor ARF in human cancer cells. While performing his dissertation research, he moonlighted in science policy as an Archer Center Fellow, and in the startup realm as an intern for the Dallas-based accelerator, Health Wildcatters.